[1]
A. Rahim-Majid and M. Babakir-Mina, “Assessment of Interleukin-31 and Calprotectin in Immunocompromised Patients with Epstein-Barr Virus Infection”, ARO, vol. 14, no. 1, pp. 120–128, Apr. 2026.